BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19434656)

  • 1. How to achieve confidence in drug discovery and development: managing risk (from a reductionist to a holistic approach).
    Bakker A; Caricasole A; Gaviraghi G; Pollio G; Robertson G; Terstappen GC; Salerno M; Tunici P
    ChemMedChem; 2009 Jun; 4(6):923-33. PubMed ID: 19434656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative strategies in drug development: clinical pharmacological aspects.
    Kuhlmann J
    Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a more robust approach to selecting and prosecuting promising targets and compounds.
    Robertson G
    Future Med Chem; 2010 Jan; 2(1):25-34. PubMed ID: 21426044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular imaging to biomarker development in neuroscience.
    Frost JJ
    Ann N Y Acad Sci; 2008 Nov; 1144():251-5. PubMed ID: 19076382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mining and visualizing the chemical content of large databases.
    Villar HO; Hansen MR
    Curr Opin Drug Discov Devel; 2009 May; 12(3):367-75. PubMed ID: 19396738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities and challenges in the discovery of new central nervous system drugs.
    Krause JE; Chenard BL
    Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correct assessment of new compounds using in vivo screening models can reduce false positives.
    Bueters TJ; Hoogstraate J; Visser SA
    Drug Discov Today; 2009 Jan; 14(1-2):89-94. PubMed ID: 18840543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative psychology and the grand challenge of drug discovery in psychiatry and neurodegeneration.
    Brunner D; Balcı F; Ludvig EA
    Behav Processes; 2012 Feb; 89(2):187-95. PubMed ID: 22155361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the search for drugs to treat central nervous system disorders.
    Enna SJ; Williams M
    J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Looking forward in pharmaceutical process chemistry.
    Davies IW; Welch CJ
    Science; 2009 Aug; 325(5941):701-4. PubMed ID: 19661417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for fMRI in optimizing CNS drug development.
    Borsook D; Becerra L; Hargreaves R
    Nat Rev Drug Discov; 2006 May; 5(5):411-24. PubMed ID: 16604100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Animal models of depression in drug discovery: a historical perspective.
    McArthur R; Borsini F
    Pharmacol Biochem Behav; 2006 Jul; 84(3):436-52. PubMed ID: 16844210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches.
    Sinko PJ
    Curr Opin Drug Discov Devel; 1999 Jan; 2(1):42-8. PubMed ID: 19649916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Needed: system dynamics for the drug discovery process.
    Sirois S; Cloutier LM
    Drug Discov Today; 2008 Aug; 13(15-16):708-15. PubMed ID: 18675763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing candidate selection--a vision in business limited conference. 1-2 December 1998, Basel, Switzerland.
    Audus KL
    IDrugs; 1999 Feb; 2(2):91-3. PubMed ID: 16160941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of drug repositioning in the current pharmaceutical market.
    Tobinick EL
    Drug News Perspect; 2009 Mar; 22(2):119-25. PubMed ID: 19330170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does human pharmacokinetic prediction add significant value to compound selection in drug discovery research?
    Beaumont K; Smith DA
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):61-71. PubMed ID: 19152214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding new drug targets in the 21st century.
    Lindsay MA
    Drug Discov Today; 2005 Dec; 10(23-24):1683-7. PubMed ID: 16376829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.